Fast neutron radiation therapy for glioblastoma multiforme. Results of an RTOG study
Between January 1977 and September 1980, 166 patients were entered on a RTOG protocol comparing neutron-boost radiotherapy with standard treatment for patients with glioblastomas. Eighty-three patients were randomized to receive a neutron boost and 83 to receive a photon boost after 50 Gy photon, whole-brain irradiation. Of these, six were ineligible and two were cancelled, leaving 158 patients available for analysis. The median survival for the neutron-boost group was 9.8 months, compared to 8.6 months for the photon-boost group. The difference is not statistically significant. Autopsies revealed actively growing persistent tumor in all photon-treated patients compared to no evidence of actively growing tumor in the majority of neutron-treated patients.
- Research Organization:
- Univ. of Washington Hospital, Seattle
- OSTI ID:
- 5075362
- Journal Information:
- Am. J. Clin. Oncol.; (United States), Vol. 6:6
- Country of Publication:
- United States
- Language:
- English
Similar Records
Fast neutron beam radiotherapy of glioblastoma multiforme
RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients
Related Subjects
ASTROCYTOMAS
RADIOTHERAPY
BRAIN
COMPARATIVE EVALUATIONS
FAST NEUTRONS
PATIENTS
PHOTONS
SURVIVAL TIME
BARYONS
BODY
CENTRAL NERVOUS SYSTEM
DISEASES
ELEMENTARY PARTICLES
FERMIONS
GLIOMAS
HADRONS
MASSLESS PARTICLES
MEDICINE
NEOPLASMS
NERVOUS SYSTEM
NEUTRONS
NUCLEAR MEDICINE
NUCLEONS
ORGANS
RADIOLOGY
THERAPY
550603* - Medicine- External Radiation in Therapy- (1980-)